Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,769
archived clinical trials in
Migraine Headaches

Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated:  10/13/2017
Cooper Univeristy Hospital
mi
from
Camden, NJ
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache
Intravenous Fluid Therapy for the Treatment of Emergency Department Patients With Migraine Headache: a Pilot Randomized Controlled Trial
Status: Enrolling
Updated: 10/13/2017
Cooper Univeristy Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage
Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated:  10/16/2017
Mayo Clinic Florida
mi
from
Jacksonville, FL
Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage
Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage
Status: Enrolling
Updated: 10/16/2017
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Sphenopalatine Ganglion Block for Treatment of Postdural Puncture Headache: A Prospective Randomized Double Blind Placebo Controlled Study
Status: Enrolling
Updated:  11/6/2017
Novant Health Forsyth Medical Center
mi
from
Winston-Salem, NC
Sphenopalatine Ganglion Block for Post-Dural Puncture Headache
Sphenopalatine Ganglion Block for Treatment of Postdural Puncture Headache: A Prospective Randomized Double Blind Placebo Controlled Study
Status: Enrolling
Updated: 11/6/2017
Novant Health Forsyth Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache
Is Paraspinal Intramuscular Ropivacaine Injection an Effective Treatment for Headache in a Pediatric Emergency Department?
Status: Enrolling
Updated:  11/16/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Study of Intramuscular Ropivacaine Injections for Treatment of Pediatric Headache
Is Paraspinal Intramuscular Ropivacaine Injection an Effective Treatment for Headache in a Pediatric Emergency Department?
Status: Enrolling
Updated: 11/16/2017
Children's Hospital of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Structural and Molecular Neuroplasticity in Migraine
Structural and Molecular Neuroplasticity in Migraine
Status: Enrolling
Updated:  11/21/2017
University of Michigan - Michigan Center for Oral Health Research
mi
from
Ann Arbor, MI
Structural and Molecular Neuroplasticity in Migraine
Structural and Molecular Neuroplasticity in Migraine
Status: Enrolling
Updated: 11/21/2017
University of Michigan - Michigan Center for Oral Health Research
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches in the Emergency Department: A Prospective Randomized, Double-blinded Trial.
Status: Enrolling
Updated:  11/27/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches in the Emergency Department: A Prospective Randomized, Double-blinded Trial.
Status: Enrolling
Updated: 11/27/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Brain Biomarkers w/Mind-Body Tx in Veterans With Post Traumatic Headache (PTH)
Neuroimaging Biomarkers of Mind-Body Treatment in Veterans With Post Traumatic Headache (PTH)
Status: Enrolling
Updated:  12/5/2017
VA West Los Angeles Medical Center
mi
from
Los Angeles, CA
Brain Biomarkers w/Mind-Body Tx in Veterans With Post Traumatic Headache (PTH)
Neuroimaging Biomarkers of Mind-Body Treatment in Veterans With Post Traumatic Headache (PTH)
Status: Enrolling
Updated: 12/5/2017
VA West Los Angeles Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
The Check Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine. A Multi-Center, Randomized Double-Blind, Clinical Control Trial.
Status: Enrolling
Updated:  12/7/2017
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
The Check Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine. A Multi-Center, Randomized Double-Blind, Clinical Control Trial.
Status: Enrolling
Updated: 12/7/2017
University Medical Center of Southern Nevada
mi
from
Las Vegas, NV
Click here to add this to my saved trials
One-Day Intervention for Depression and Impairment in Migraine Patients
One-Day Intervention for Depression and Impairment in Migraine Patients
Status: Enrolling
Updated:  12/20/2017
University of Iowa Carver College of Medicine Department of Psychiatry
mi
from
Iowa City, IA
One-Day Intervention for Depression and Impairment in Migraine Patients
One-Day Intervention for Depression and Impairment in Migraine Patients
Status: Enrolling
Updated: 12/20/2017
University of Iowa Carver College of Medicine Department of Psychiatry
mi
from
Iowa City, IA
Click here to add this to my saved trials
Amitriptyline to Prevent Headache After Traumatic Brain Injury
Amitriptyline to Prevent Headache After Traumatic Brain Injury
Status: Enrolling
Updated:  12/21/2017
Harborview Medical Center
mi
from
Seattle, WA
Amitriptyline to Prevent Headache After Traumatic Brain Injury
Amitriptyline to Prevent Headache After Traumatic Brain Injury
Status: Enrolling
Updated: 12/21/2017
Harborview Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Patent Foramen Ovale in Children With Migraine Headaches
Patent Foramen Ovale in Children With Migraine Headaches
Status: Enrolling
Updated:  12/21/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Patent Foramen Ovale in Children With Migraine Headaches
Patent Foramen Ovale in Children With Migraine Headaches
Status: Enrolling
Updated: 12/21/2017
Primary Children's Medical Center
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients
Phase I, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Single Dose Study to Evaluate the Blockade of CGRP Receptor by AMG 334 in Preventing PACAP-38 Induced Migraine-like Attacks in Migraine Patients
Status: Enrolling
Updated:  12/22/2017
Clinical Research Facility
mi
from
Anaheim, CA
To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients
Phase I, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Single Dose Study to Evaluate the Blockade of CGRP Receptor by AMG 334 in Preventing PACAP-38 Induced Migraine-like Attacks in Migraine Patients
Status: Enrolling
Updated: 12/22/2017
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients
Phase I, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Single Dose Study to Evaluate the Blockade of CGRP Receptor by AMG 334 in Preventing PACAP-38 Induced Migraine-like Attacks in Migraine Patients
Status: Enrolling
Updated:  12/22/2017
mi
from
Leuven,
To Evaluate the Blockade of CGRP in Preventing PACAP-38 Induced Migraine-like Attacks With AMG 334 in Migraine Patients
Phase I, Randomized, Parallel-group, Double-Blind, Placebo-Controlled, Single Dose Study to Evaluate the Blockade of CGRP Receptor by AMG 334 in Preventing PACAP-38 Induced Migraine-like Attacks in Migraine Patients
Status: Enrolling
Updated: 12/22/2017
mi
from
Leuven,
Click here to add this to my saved trials
Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT
Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT
Status: Enrolling
Updated:  1/3/2018
Harbor UCLA Medical Center
mi
from
Torrance, CA
Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT
Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT
Status: Enrolling
Updated: 1/3/2018
Harbor UCLA Medical Center
mi
from
Torrance, CA
Click here to add this to my saved trials
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
A Randomized, Double-Blind, Three Period, Cross-Over Study to Evaluate the Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan (Imitrex) in Healthy Male and Female Subjects
Status: Enrolling
Updated:  1/10/2018
SNBL Clinical Pharmacology Unit
mi
from
Baltimore, MD
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
A Randomized, Double-Blind, Three Period, Cross-Over Study to Evaluate the Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan (Imitrex) in Healthy Male and Female Subjects
Status: Enrolling
Updated: 1/10/2018
SNBL Clinical Pharmacology Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function
Status: Enrolling
Updated:  1/11/2018
Orlando Clinical Research Center
mi
from
Orlando, FL
Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function
Status: Enrolling
Updated: 1/11/2018
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function
Status: Enrolling
Updated:  1/11/2018
NOCCR
mi
from
Knoxville, KY
Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function
Status: Enrolling
Updated: 1/11/2018
NOCCR
mi
from
Knoxville, KY
Click here to add this to my saved trials
Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function
Status: Enrolling
Updated:  1/11/2018
Altasciences Company Inc./Algorithme Pharma
mi
from
Mount-Royal,
Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function
A Phase I, Multicenter, Open-Label, Parallel-Group, Pharmacokinetic Single Dose Study of Oral Lasmiditan in Subjects With Normal and Impaired Hepatic Function
Status: Enrolling
Updated: 1/11/2018
Altasciences Company Inc./Algorithme Pharma
mi
from
Mount-Royal,
Click here to add this to my saved trials
"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"
"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"
Status: Enrolling
Updated:  1/16/2018
Brooke Army Medical Center
mi
from
San Antonio, TX
"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"
"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"
Status: Enrolling
Updated: 1/16/2018
Brooke Army Medical Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Lasmiditan in Participants With Migraine
An Open-Label, Two-Period Study to Evaluate the Pharmacokinetics of Lasmiditan in Migraineurs During Acute Migraine Attacks and During Inter-Ictal Periods
Status: Enrolling
Updated:  1/17/2018
eStudySite
mi
from
San Diego, CA
A Study of Lasmiditan in Participants With Migraine
An Open-Label, Two-Period Study to Evaluate the Pharmacokinetics of Lasmiditan in Migraineurs During Acute Migraine Attacks and During Inter-Ictal Periods
Status: Enrolling
Updated: 1/17/2018
eStudySite
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of Lasmiditan in Participants With Migraine
An Open-Label, Two-Period Study to Evaluate the Pharmacokinetics of Lasmiditan in Migraineurs During Acute Migraine Attacks and During Inter-Ictal Periods
Status: Enrolling
Updated:  1/17/2018
AGA Clinical Trials
mi
from
Hialeah, FL
A Study of Lasmiditan in Participants With Migraine
An Open-Label, Two-Period Study to Evaluate the Pharmacokinetics of Lasmiditan in Migraineurs During Acute Migraine Attacks and During Inter-Ictal Periods
Status: Enrolling
Updated: 1/17/2018
AGA Clinical Trials
mi
from
Hialeah, FL
Click here to add this to my saved trials
A Study of Lasmiditan in Participants With Migraine
An Open-Label, Two-Period Study to Evaluate the Pharmacokinetics of Lasmiditan in Migraineurs During Acute Migraine Attacks and During Inter-Ictal Periods
Status: Enrolling
Updated:  1/17/2018
Meridien Research
mi
from
Tampa, FL
A Study of Lasmiditan in Participants With Migraine
An Open-Label, Two-Period Study to Evaluate the Pharmacokinetics of Lasmiditan in Migraineurs During Acute Migraine Attacks and During Inter-Ictal Periods
Status: Enrolling
Updated: 1/17/2018
Meridien Research
mi
from
Tampa, FL
Click here to add this to my saved trials
Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Naratriptan Hydrochloride 2.5 mg Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
Charles River Northwest Kinetics
mi
from
Tacoma, WA
Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fed Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Naratriptan Hydrochloride 2.5 mg Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
Charles River Northwest Kinetics
mi
from
Tacoma, WA
Click here to add this to my saved trials
Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Naratriptan Hydrochloride 2.5 mg Tablets Under Fasted Conditions
Status: Enrolling
Updated:  1/19/2018
Charles River Northwest Kinetics
mi
from
Tacoma, WA
Bioequivalency Study of Naratriptan Hydrochloride 2.5 mg Under Fasted Conditions
A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalence Study of Naratriptan Hydrochloride 2.5 mg Tablets Under Fasted Conditions
Status: Enrolling
Updated: 1/19/2018
Charles River Northwest Kinetics
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency
A Randomized, Pilot Study to Evaluate the Tolerability of OnabotulinumtoxinA Plus Topiramate vs. OnabotulinumtoxinA Plus Placebo and Long Term Effect of Treatment on Cognitive Efficiency and Continuation of Care
Status: Enrolling
Updated:  1/23/2018
Clinvest/A Division of Banyan Group, Inc.
mi
from
Springfield, MO
A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive Efficiency
A Randomized, Pilot Study to Evaluate the Tolerability of OnabotulinumtoxinA Plus Topiramate vs. OnabotulinumtoxinA Plus Placebo and Long Term Effect of Treatment on Cognitive Efficiency and Continuation of Care
Status: Enrolling
Updated: 1/23/2018
Clinvest/A Division of Banyan Group, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Brief Behavioral Intervention for Comorbid Migraine and Depression
Brief, Behavioral Intervention of ACT & Illness Management for Comorbid Migraine and Depression
Status: Enrolling
Updated:  1/24/2018
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Brief Behavioral Intervention for Comorbid Migraine and Depression
Brief, Behavioral Intervention of ACT & Illness Management for Comorbid Migraine and Depression
Status: Enrolling
Updated: 1/24/2018
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
Use of the Tx360 Nasal Applicator for Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine: A Double-blind Placebo-controlled Study
Status: Enrolling
Updated:  1/25/2018
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
Use of the Tx360 Nasal Applicator for Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine: A Double-blind Placebo-controlled Study
Status: Enrolling
Updated: 1/25/2018
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
Use of the Tx360 Nasal Applicator for Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine: A Double-blind Placebo-controlled Study
Status: Enrolling
Updated:  1/25/2018
Clinvest/A Division of Banyan Group, Inc.
mi
from
Springfield, MO
Use of the Tx360 Nasal Applicator in the Treatment of Chronic Migraine
Use of the Tx360 Nasal Applicator for Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine: A Double-blind Placebo-controlled Study
Status: Enrolling
Updated: 1/25/2018
Clinvest/A Division of Banyan Group, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects
Open-Label, Three Way, Randomized, Single Dose Crossover Study Comparing Bioavailability of DFN-15 Oral Solution Under Fasting Conditions vs Comparator Under Fed Conditions and to Determine Food Effect of DFN-15 in Healthy Adult Subjects
Status: Enrolling
Updated:  2/10/2018
Celerion
mi
from
Lincoln, NE
Study on the Pharmacokinetics (PK) of DFN-15 vs Comparator and Food-effect on DFN-15 PK in Healthy Adult Subjects
Open-Label, Three Way, Randomized, Single Dose Crossover Study Comparing Bioavailability of DFN-15 Oral Solution Under Fasting Conditions vs Comparator Under Fed Conditions and to Determine Food Effect of DFN-15 in Healthy Adult Subjects
Status: Enrolling
Updated: 2/10/2018
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Arizona Research Center
mi
from
Phoenix, AZ
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Arizona Research Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Northern California Clinical Research Center
mi
from
Redding, CA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Northern California Clinical Research Center
mi
from
Redding, CA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
San Francisco Clinical Research Center
mi
from
San Francisco, CA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
San Francisco Clinical Research Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
California Medical Clinic for Headache
mi
from
Santa Monica, CA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
California Medical Clinic for Headache
mi
from
Santa Monica, CA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Associated Neurologists of Southern Ct., PC
mi
from
Fairfield, CT
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Associated Neurologists of Southern Ct., PC
mi
from
Fairfield, CT
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Florida Clinical Research Center LLC
mi
from
Maitland, FL
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Neurology Clinical Research Inc.
mi
from
Sunrise, FL
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Neurology Clinical Research Inc.
mi
from
Sunrise, FL
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Carman Research
mi
from
Smyrna, GA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Carman Research
mi
from
Smyrna, GA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Novex Clinical Research, LLC
mi
from
New Bedford, MA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Novex Clinical Research, LLC
mi
from
New Bedford, MA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
MedVadis Research Corporation
mi
from
Watertown, MA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
MedVadis Research Corporation
mi
from
Watertown, MA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Michigan Head Pain & Neurological Institute
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Clinvest/A Division of Banyan Group, Inc.
mi
from
Springfield, MO
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Clinvest/A Division of Banyan Group, Inc.
mi
from
Springfield, MO
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Albuquerque Clinical Trials
mi
from
Albuquerque, NM
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
DENT Neurologic Institute
mi
from
Amherst, NY
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
DENT Neurologic Institute
mi
from
Amherst, NY
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Upstate Clinical Research Associates
mi
from
Williamsville, NY
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Upstate Clinical Research Associates
mi
from
Williamsville, NY
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Community Research
mi
from
Cincinnati, OH
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Community Research
mi
from
Cincinnati, OH
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
Thomas Jefferson University
mi
from
Philadelphia, PA
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated:  2/11/2018
FutureSearch Trials of Neurology, LP
mi
from
Austin, TX
DFN-02 Open Label Safety Study in Patients With Acute Migraine
Status: Enrolling
Updated: 2/11/2018
FutureSearch Trials of Neurology, LP
mi
from
Austin, TX
Click here to add this to my saved trials